EFFICACY AND SAFETY OF BOSUTINIB IN PATIENTS WITH RESISTANT CHRONIC MYELOID LEUKAEMIA OR INTOLERANT TO ATLEAST 3 INHIBITORS OF PRIOR TYROSINE KINASE

被引：0

作者：

Valentin, Garcia-Gutierrez ^{[1
]}

Dragana, Milojkovic ^{[2
]}

Luis Felipe, Casado ^{[3
]}

Simone, Claudiani ^{[2
]}

Antonio, Jimenez-Velasco ^{[4
]}

Maria Luisa, Marten-Mateos ^{[5
]}

Concepcion, Boque ^{[6
]}

Alejandra, Martinez-Trillo ^{[7
]}

Isabel, Mata ^{[8
]}

Payer Angel, Ramirez ^{[9
]}

Alberto, Alvarez-Larran ^{[10
]}

Elena, Amutio ^{[11
]}

Garcia Abelardo, Barez ^{[12
]}

Guiomar, Bautista ^{[13
]}

Barela Sabela, Bobillo ^{[14
]}

Ruiz Beatriz, Cuevas ^{[15
]}

Pilar, Giraldo ^{[16
]}

Jose Manuel, Puerta ^{[17
]}

Maria Jose, Ramirez ^{[18
]}

Gerosa Silvana, Saavedra ^{[19
]}

Sandra, Valencia ^{[20
]}

Rivas Fernando, Ortega ^{[21
]}

Mas Ana, Rossel ^{[22
]}

Fabio, Ruiz ^{[23
]}

Juan Luis, Steegmann ^{[24
,25
]}

机构：

[1] Hosp Univ Ramon y Cajal, Serv Hematol & Hemoterapia, Madrid, Spain

[2] Imperial Coll, Hammersmith Hosp, London, England

[3] Hosp Virgen de la Salud, Toledo, Spain

[4] 8Hosp Univ Carlos Haya, Malaga, Spain

[5] Hosp San Pedro de Alcantara, Serv Hematol, Caceres, Spain

[6] Insitute Cotele Oncol, Barcelona, Spain

[7] Hosp Clin Barcelona, Serv Hematol, Barcelona, Spain

[8] Hosp Costa Sol, Malaga, Spain

[9] Hosp Univ Cent Asturias, Oviedo, Spain

[10] Hosp del Mar, Serv Hematol, Barcelona, Spain

[11] Hosp Cruces, Vizcaya, Spain

[12] Hosp Nuestra Senora Sonsoles, Serv Hematol, Avila, Spain

[13] Hosp Univ Puerta de Hierro, Serv Hematol, Majadahonda, Spain

[14] Hosp Valle De Hebron, Barcelona, Spain

[15] Hosp Univ Burgos, Burgos, Spain

[16] Miguel Servet Univ Hosp, Haematol, Zaragoza, Spain

[17] Hosp Univ Virgen de las Nieves, Unidad Gest Clin Hematol & Hemoterapia, Granada, Spain

[18] Hosp Jerez Frontera, Serv Hematol, Cadiz, Spain

[19] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[20] Hosp Segovia, Serv Hematol, Segovia, Spain

[21] Hosp Palencia, Hematol 29Serv, Palencia, Spain

[22] 33Hosp Virgen de la Victoria, Malaga, Spain

[23] Hosp Univ Ramon y Cajal, Serv Hematol & Hemoterapia, Madrid, Spain

[24] Hosp Princesa, Hematol, Madrid, Spain

[25] Hosp Princesa, IIS IP, Madrid, Spain

来源：

HAEMATOLOGICA | 2016年 / 101卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

CO-126

引用

页码：79 / 80

页数：2

共 50 条

[11] Adherence assessment in Chronic Myeloid Leukaemia patients treated by tyrosine kinase inhibitors
Daouphars, M.
Ouvry, M.
Lenain, P.
Rouvet, J.
Varin, R.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2011, 33 (02) : 414 - 415
[12] Treatment adherence in chronic myeloid leukaemia patients receiving tyrosine kinase inhibitors
Rychter, Anna
Jerzmanowski, Piotr
Holub, Adam
Specht-Szwoch, Zofia
Kalinowska, Violetta
Tegowska, Urszula
Seferynska, Ilona
Kolkowska-Lesniak, Agnieszka
Lech-Maranda, Ewa
Gora-Tybor, Joanna
MEDICAL ONCOLOGY, 2017, 34 (06)
[13] Adverse outcomes in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
Papaila, Alexa
Godding, Mark
Liu, Michael
HEART, 2021, 107 (20) : 1680 - 1680
[14] Quality of Life of Ghanaian Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitors
Kuma, A. Benneh-Akwasi
Amponsah, E.
Kyeremeh, R.
Olayemi, E.
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 181 : 67 - 68
[15] Comparative efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukaemia: A systematic review and network meta-analysis
Fachi, Mariana M.
Tonin, Fernanda S.
Leonart, Leticia P.
Aguiar, Karina S.
Lenzi, Luana
Figueiredo, Bonald C.
Fernandez-Llimos, Fernando
Pontarolo, Roberto
EUROPEAN JOURNAL OF CANCER, 2018, 104 : 9 - 20
[16] Dasatinib Treatment for Imatinib Resistant or Intolerant Patients with Chronic Myeloid Leukaemia
Li, J.
Xu, G.
Yu, S.
He, L.
Guo, L.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2011, 39 (02) : 337 - 347
[17] Efficacy and safety of nilotinib 300 mg twice daily in patients with chronic myeloid leukemia in chronic phase who are intolerant to prior tyrosine kinase inhibitors: Results from the Phase IIIb ENESTswift study
Hiwase, Devendra
Tan, Peter
D'Rozario, James
Taper, John
Powell, Anthony
Irving, Ian
Wright, Matthew
Branford, Susan
Yeung, David T.
Anderson, Luke
Gervasio, Othon
Levetan, Carly
Roberts, Will
Solterbeck, Ann
Traficante, Robert
Hughes, Timothy
LEUKEMIA RESEARCH, 2018, 67 : 109 - 115
[18] Cross-Intolerance with Bosutinib after Prior Tyrosine Kinase Inhibitors in Patients with Chronic Phase Chronic Myeloid Leukemia: BYOND Phase 4 Study
Gjertsen, Bjorn T.
Hochhaus, Andreas
Rosti, Gianantonio
Watts, Justin M.
Orti, Guillermo
le Coutre, Philipp
Leip, Eric
Viqueira, Andrea
Cortes, Jorge E.
Giles, Frank
Gambacorti-Passerini, Carlo
BLOOD, 2019, 134
[19] Pharmacokinetics of Four Tyrosine Kinase Inhibitors in Adult and Paediatric Chronic Myeloid Leukaemia Patients
Allegra, Sarah
Dondi, Emma
Chiara, Francesco
De Francia, Silvia
BIOMEDICINES, 2023, 11 (09)
[20] Incidence of cardiovascular events in patients with chronic myeloid leukaemia treated with tyrosine kinase inhibitors
Casavecchia, Grazia
Spinosa, Giuseppina
De Gennaro, Luisa
Zicchino, Stefano
Gravina, Matteo
Magnesa, Michele
Di Biase, Matteo
Brunetti, Natale Daniele
ACTA CARDIOLOGICA, 2022, 77 (02) : 130 - 135

← 1 2 3 4 5 →